Dana-Farber Cancer Institute: all 832 studies

Page 1 of 9. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.

• Roginolisib Plus Obinutuzumab + Venetoclax in R/R CLLNot yet recruitingNCT07847957Phase 1/2
• Imlunestrant/Abemaciclib/Selinexor in Ovarian and EndometrialNot yet recruitingNCT07832227Phase 2
• Healing Gardens: Leveraging Serious Games to Deliver Accessible Pain-CBT and Pharmacologic Support for Patients With Advanced Cancer Managing PainNot yet recruitingNCT07825051Not applicable
• Pedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expression in Relapsed/Refractory Pediatric Solid and CNS TumorsNot yet recruitingNCT07793994Not applicable
• RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal CancerRecruitingNCT07735624Phase 2
• BRIDGE-SIC Efficacy TrialRecruitingNCT07735442Not applicable
• Listen Aphasia Pilot StudyNot yet recruitingNCT07732140Not applicable
• Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot FlashesRecruitingNCT07729150Not applicable
• Zanzalintinib in Unresectable and Progressive MPGGsNot yet recruitingNCT07714551Phase 2
• Neurocognitive Assessment CNSL and LGGNot yet recruitingNCT07710131Not applicable
• Clonal Hematopoiesis Chemotherapy and Radiation Effects StudyRecruitingNCT07675967
• Breast and Cervical Cancer Stigma in RwandaNot yet recruitingNCT07663006Not applicable
• Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot InterventionRecruitingNCT07662239Not applicable
• D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMMRecruitingNCT07624513Phase 3
• Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed MyelomaNot yet recruitingNCT07601100Phase 1/2
• Adjuvant Endocrine Therapy Adherence Intervention Pilot in RwandaNot yet recruitingNCT07562399Not applicable
• SMARCA4/2 Inhibitor for POU2F3-Positive SCLCRecruitingNCT07551635Phase 2
• Acupuncture and Exercise for EV-Pembro-Induced Peripheral NeuropathyRecruitingNCT07548476Not applicable
• my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young AdultsNot yet recruitingNCT07516353Not applicable
• Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast CancerNot yet recruitingNCT07499999Phase 2
• Supporting Health Including Endocrine Treatment for Long DurationRecruitingNCT07482384Not applicable
• Ph 2 Elacestrant in ER Positive Uterine SarcomasRecruitingNCT07467772Phase 2
• Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCCRecruitingNCT07465276Phase 2
• PH 2 Pemigatinib in SDH-deficient GISTRecruitingNCT07434843Phase 2
• Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyRecruitingNCT07426484Phase 4
• Precise Exercise Regimen for Cancer Care (PERCC): A Pilot StudyRecruitingNCT07412041Not applicable
• Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCCRecruitingNCT07397611Phase 2
• The DISCOVER StudyNot yet recruitingNCT07390643Not applicable
• On-Trac: An Online Intervention for Cancer Survivors Managing AnxietyRecruitingNCT07305740Not applicable
• ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRsRecruitingNCT07232043Not applicable
• ALL Backbone in AYAsRecruitingNCT07227584Phase 2
• Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO StudyRecruitingNCT07123649Phase 2
• Cryocompression for CIPNRecruitingNCT07064798Not applicable
• ACT Lung Health Intervention: Phase TwoRecruitingNCT06945120Not applicable
• Toripalimab With Chemotherapy for Sinus CancerRecruitingNCT06940180Phase 2
• BOLSTER: Learning New Skills to ThriveRecruitingNCT06936878Not applicable
• Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND TrialRecruitingNCT06923397Not applicable
• Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta TestingRecruitingNCT06907797Not applicable
• Resource Intervention to Support Equity (RISE) in High-Risk NeuroblastomaRecruitingNCT06831552Not applicable
• A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland CancersRecruitingNCT06805617Phase 2
• Sleep Treatment Education Program for Cancer Survivors: STEP-TogetherEnrolling by invitationNCT06736548Not applicable
• EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx PopulationsRecruitingNCT06716580Not applicable
• REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP InhibitorsRecruitingNCT06710548Not applicable
• Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginRecruitingNCT06677190Phase 2
• A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative ExcisionRecruitingNCT06664151Early Phase 1
• Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality StudyRecruitingNCT06623097Not applicable
• Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer SurvivorsRecruitingNCT06609473Not applicable
• Elranatamab in Patients With Relapsed or Refractory AL AmyloidosisRecruitingNCT06569147Phase 1/2
• The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL TrialRecruitingNCT06565052Not applicable
• Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian CancerRecruitingNCT06543537Not applicable
• Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel StudyRecruitingNCT06523868Not applicable
• The COMPASSION StudyRecruitingNCT06507930Not applicable
• Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast CancerRecruitingNCT06488378Phase 1
• HEME Home Transfusion ProgramRecruitingNCT06487247Not applicable
• Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSLRecruitingNCT06475235Phase 1
• Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)RecruitingNCT06469307Not applicable
• Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant PatientsRecruitingNCT06468618Not applicable
• Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM StudyRecruitingNCT06450171Not applicable
• The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast CancerRecruitingNCT06439693Phase 2
• ALPINE: Maintenance Letrozole/AbemaciclibRecruitingNCT06366347Phase 2
• Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian CancerRecruitingNCT06321484Phase 1
• PediRISE FeasibilityRecruitingNCT06283251Not applicable
• PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCCRecruitingNCT06239220Phase 2
• CV CARE: CardioVascular Care in PC PatientsRecruitingNCT06202820Not applicable
• Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE TrialRecruitingNCT06202183Not applicable
• CIML NK Cells With Venetoclax for AMLRecruitingNCT06152809Phase 1
• Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell TransplantationRecruitingNCT06138587Phase 1
• Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric AssessmentsRecruitingNCT06138561
• Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk IndividualsRecruitingNCT06122896Early Phase 1
• Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) TestingRecruitingNCT06117709Not applicable
• Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE TrialRecruitingNCT06040125Not applicable
• Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With CancerRecruitingNCT06038318Not applicable
• Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE TrialRecruitingNCT06026111Not applicable
• BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)RecruitingNCT05922761Phase 2
• Development and Testing of Nutritional Algorithms (NACHO)Not yet recruitingNCT05825469Not applicable
• RecoverPC: Relugolix vs GnRH Agonist in Quality of LifeRecruitingNCT05765500Phase 2
• High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility StudyRecruitingNCT05740839Not applicable
• Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCCRecruitingNCT05726370Phase 2
• Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationRecruitingNCT05706766Not applicable
• Investigating Hereditary Risk In Thoracic Cancers (INHERIT)RecruitingNCT05587439
• TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer PatientsRecruitingNCT05535192Not applicable
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
• Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD TrialRecruitingNCT05356117Not applicable
• Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell TransplantationRecruitingNCT05335434Not applicable
• Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation TherapyRecruitingNCT05327465Not applicable
• Biology of Young Lung Cancer Study: The YOUNG LUNG StudyRecruitingNCT05265429
• Zanubrutinib and Venetoclax in CLL (ZANU-VEN)RecruitingNCT05168930Phase 2
• Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving ChemotherapyRecruitingNCT04997096Not applicable
• Scalp Cooling in MBCRecruitingNCT04986579Phase 2
• Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy SpecimensRecruitingNCT04968834
• ATEMPT 2.0: Adjuvant T-DM1 vs THRecruitingNCT04893109Phase 2
• Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR TrialRecruitingNCT04883671Not applicable
• Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial NeoplasiaRecruitingNCT04839614Not applicable
• Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic CancerRecruitingNCT04789486Phase 1/2
• Sacituzumab Govitecan Plus EV in Metastatic UCRecruitingNCT04724018Phase 1/2
• IS-free Treg HaploHCTRecruitingNCT04678401Phase 1
• Resilience and Equity in Aging, Cancer, and Health (REACH)RecruitingNCT04674267Not applicable
• Refining Local-Regional Therapy for IBCRecruitingNCT04636710Not applicable
• Geriatric Thoracic Surgery Ambulation ChallengeRecruitingNCT04630496Not applicable
• Post-op T-DM1 in HER-2+ Salivary Gland CarcinomasRecruitingNCT04620187Phase 2

← Dana-Farber Cancer Institute overview and focus areas